Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Assets: 2022-2024

Historic Non-Current Assets for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $37.4 million.

  • Abivax's Non-Current Assets fell 15.06% to $38.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $38.0 million, marking a year-over-year decrease of 15.06%. This contributed to the annual value of $37.4 million for FY2024, which is 15.85% down from last year.
  • Per Abivax's latest filing, its Non-Current Assets stood at $37.4 million for FY2024, which was down 15.85% from $44.4 million recorded in FY2023.
  • Abivax's Non-Current Assets' 5-year high stood at $44.4 million during FY2023, with a 5-year trough of $37.4 million in FY2024.
  • For the 3-year period, Abivax's Non-Current Assets averaged around $41.1 million, with its median value being $41.5 million (2022).
  • Its Non-Current Assets has fluctuated over the past 5 years, first grew by 7.14% in 2023, then dropped by 15.85% in 2024.
  • Yearly analysis of 3 years shows Abivax's Non-Current Assets stood at $41.5 million in 2022, then rose by 7.14% to $44.4 million in 2023, then dropped by 15.85% to $37.4 million in 2024.